info@mail.ucallm.com
From Chromatin Remodeling to Gene Regulation — Empowering Comprehensive Epigenetic Discovery with Validated Histone Modification Antibody Solutions
Histone modifications represent a fundamental layer of epigenetic regulation that governs chromatin architecture, DNA accessibility, transcriptional activity, genome stability, and cellular identity. Beyond their role as structural components of chromatin, histone modifications act as dynamic molecular signals that regulate gene expression programs during development, differentiation, stress adaptation, aging, and disease progression.
Histone proteins undergo diverse post-translational modifications (PTMs), including methylation, acetylation, phosphorylation, ubiquitination, lactylation, crotonylation, succinylation, and other emerging metabolism-associated modifications. These reversible modifications are precisely regulated by histone-modifying enzymes and interpreted by chromatin-associated proteins, transcription factors, and epigenetic regulatory complexes to establish functional chromatin states, including Histone tails undergo diverse post-translational modifications (PTMs), including:
- Methylation
- Acetylation
- Phosphorylation
- Ubiquitination
- Lactylation
- Crotonylation
- Succinylation
- Other emerging metabolic-associated modifications
Dysregulated histone modification patterns can disrupt normal chromatin function and contribute to diverse biological and pathological processes, including:
- Cancer initiation, progression, and therapeutic resistance
- Chromatin instability and genome maintenance defects
- Neurodevelopmental disorders and neurodegenerative diseases
- Stem cell self-renewal and lineage specification
- Immune-cell differentiation and inflammatory regulation
- Aging-associated epigenomic remodeling
- Metabolic adaptation and disease-associated transcriptional reprogramming
We provide comprehensive antibody solutions for investigating histone biology—from global chromatin profiling and histone modification mapping to functional analysis of epigenetic regulatory mechanisms. Validated histone modification antibodies enable researchers to characterize:
- Active and repressive chromatin states
- Promoter and enhancer regulation
- Transcription-associated histone modifications
- DNA damage-associated histone responses
- Chromatin remodeling during development and disease progression
- Emerging metabolism-linked histone modifications
By integrating high-quality histone modification antibodies with advanced chromatin profiling approaches, researchers can decode complex epigenetic regulatory networks, identify disease-associated chromatin signatures, and accelerate discoveries in cancer biology, neuroscience, immunology, developmental biology, stem cell research, aging research, and precision medicine.
Core Histone Modification Antibody Portfolio
——Comprehensive Solutions for Chromatin State Mapping, Epigenetic Regulation, and Functional Mechanism Discovery
Histone modifications represent dynamic epigenetic signals that regulate chromatin accessibility, transcriptional activity, genome stability, DNA repair, and cellular identity.
Our validated histone modification antibody portfolio enables systematic profiling of functional chromatin states, from transcriptional activation and gene repression to DNA damage responses, chromosome regulation, and emerging metabolism-associated epigenetic mechanisms.
Research Focus | Representative Biomarkers | Research Applications |
Active Chromatin & Transcriptional Activation | H3K4me3 H3K27ac H3K9ac H3K4me1 H3K36me3 | Identification of transcriptionally active chromatin regions, including active promoters, enhancers, and gene regulatory elements; analysis of transcriptional activation programs during development, differentiation, and disease progression |
Repressive Chromatin & Gene Silencing | H3K27me3 H3K9me3 H4K20me3 H2AK119ub | Characterization of heterochromatin formation, Polycomb-mediated repression, and stable gene silencing mechanisms involved in development, cancer progression, and cell identity regulation |
DNA Damage Response & Genome Stability | γH2AX (H2AXS139ph) H4K20me2 H2AK13/15ub | Monitoring DNA double-strand break formation, repair pathway activation, chromatin remodeling after damage, and genome maintenance mechanisms |
Cell Cycle & Chromosome Dynamics | H3S10ph H3S28ph H3T3ph | Investigation of mitotic chromosome condensation, chromosomal organization, and cell-cycle-dependent chromatin remodeling |
Emerging Metabolism-Associated Histone PTMs | H3K18la H3K9la H3K27cr H3K122succ H3K9bhb | Exploration of metabolism–epigenome interactions, including lactylation, crotonylation, succinylation, and β-hydroxybutyrylation-mediated transcriptional regulation in cancer, immunity, metabolism, and aging |
Featured Histone Modification Research Panels
——Comprehensive Antibody Panels for Chromatin State Profiling, Epigenetic Mechanism Discovery, and Disease-Oriented Research
Histone modifications represent dynamic regulatory signals that define chromatin states, control transcriptional programs, and influence cellular identity. Our curated histone modification antibody panels enable researchers to systematically investigate chromatin activation, transcriptional repression, DNA damage responses, developmental regulation, and disease-associated epigenetic remodeling.
Active Chromatin & Transcription Regulation Panel—Mapping Transcriptionally Permissive Chromatin States and Regulatory Elements
Key Markers
H3K4me3 | H3K27ac | H3K9ac | H3K36me3 | H3K4me1 |
Cancer Epigenetics & Therapeutic Response Panel—Investigating Aberrant Chromatin Remodeling in Tumor Biology
Key Markers
H3K27me3 | H3K27ac | H3K9me3 | EZH2 | HDAC1/2 |
Neuroepigenetics & Developmental Regulation Panel—Exploring Chromatin Remodeling During Neural Development and Disease
Key Markers
H3K27ac | H3K27me3 | H3K9me3 | H4K16ac | MeCP2 |
Emerging Metabolism-Associated Histone Modification Panel—Connecting Cellular Metabolism with Epigenetic Regulation
Key Markers
H3K9la | H3K18la | H3K27cr | H3K122succ | H3K9bhb |
Why Researchers Choose Our Histone Modification Antibody Solutions
Validated Epigenetic Targets. Comprehensive Chromatin Panels. Reliable Research Outcomes.
Our histone antibody portfolio supports complete epigenetic research workflows:
Research Challenge | Our Solution |
How can I identify active chromatin regions? | H3K4me3, H3K27ac, H3K9ac antibodies |
How can I study gene repression? | H3K27me3, H3K9me3, H4K20me3 markers |
How can I analyze DNA damage responses? | γH2AX and DNA repair-associated antibodies |
How can I investigate cancer epigenetics? | Histone modification and chromatin regulator panels |
How can I explore emerging epigenetic mechanisms? | Lactylation, crotonylation, and metabolic PTM antibodies |
How can I improve reproducibility? | Validated antibodies optimized for WB, IF, IHC, ChIP, and multiplex applications |
Key reference
Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Ther. 2024 Sep 16;9(1):232.
Zhao A, Xu W, Han R, Wei J, Yu Q, Wang M, Li H, Li M, Chi G. Role of histone modifications in neurogenesis and neurodegenerative disease development. Ageing Res Rev. 2024 Jul;98:102324.
Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Semin Cancer Biol. 2022 Aug;83:452-471.
Sinha KK, Bilokapic S, Du Y, Malik D, Halic M. Histone modifications regulate pioneer transcription factor cooperativity. Nature. 2023 Jul;619(7969):378-384.
Park J, Lee K, Kim K, Yi SJ. The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther. 2022 Jul 6;7(1):217.
Jin ML, Jeong KW. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. Exp Mol Med. 2023 Jul;55(7):1333-1347.
Hedehus L, Mas AM, Alpsoy A, Armstrong RL, Koche R, Tatar T, Wang H, Helin K. Addressing the specific roles of histone modifications in transcriptional repression. Nat Commun. 2025 Nov 22;16(1):11326.